← Eichor
Condition: Dual Antiplatelet Therapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dual Antiplatelet Therapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding
Phase 4 · 1 location(s) · University of Florida · NCT07025148Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
Phase 4 · 1 location(s) · University of Florida · NCT05681702The Study to Evaluate the Safety and Efficacy of the Onyx Family
Phase N/A · 1 location(s) · Pusan National University Yangsan Hospital · NCT06577896OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina
NA · 1 location(s) · Korea University Guro Hospital · NCT07198529Ticagrelore Alone Post PCI
Phase 4 · 2 location(s) · Shiraz University of Medical Sciences · NCT06509893Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
Phase N/A · 3 location(s) · Xueyan Zhao · NCT07523880Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
Phase 3 · 1 location(s) · Montreal Heart Institute · NCT07257198Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M
Phase 3 · 1 location(s) · Samsung Medical Center · NCT07467213Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05028777Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
Phase 4 · 2 location(s) · Samsung Medical Center · NCT04014803Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet
NA · 1 location(s) · SUK MIN SEO · NCT07479056Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting On
NA · 1 location(s) · Yonsei University · NCT05320926Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction
Phase 4 · 6 location(s) · Rikke Sorensen · NCT05262803Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NA · 3 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05732701Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease
Phase N/A · 1 location(s) · Genoss Co., Ltd. · NCT06075420Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
Phase 4 · 27 location(s) · Research Maatschap Cardiologen Rotterdam Zuid · NCT05491200PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
Phase 4 · 1 location(s) · Kindai University · NCT05709626DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial
NA · 1 location(s) · Yonsei University · NCT05305482Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
Phase 4 · 18 location(s) · Second Affiliated Hospital of Soochow University · NCT07095790STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
NA · 2 location(s) · IGLESIAS Juan Fernando · NCT05785897Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke
Phase 2/Phase 3 · 1 location(s) · Mazandaran University of Medical Sciences · NCT06653348Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease A
Phase N/A · 1 location(s) · Genoss Co., Ltd. · NCT06075433Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gast
Phase 4 · 45 location(s) · Duk-Woo Park, MD · NCT04416581Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
Phase N/A · 1 location(s) · University of Virginia · NCT06292117What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Phase 4 · 20 location(s) · St. Antonius Hospital · NCT04436978Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease
Phase N/A · 8 location(s) · Sigmund Freud PrivatUniversitat · NCT07299994Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome:
Phase N/A · 1 location(s) · Samsung Medical Center · NCT07068490Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Phase N/A · 2 location(s) · Jordan Collaborating Cardiology Group · NCT07039149Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percu
Phase 4 · 3 location(s) · Odense University Hospital · NCT06718179Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Followin
Phase 3 · 18 location(s) · Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi · NCT07195149
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.